Event-Driven Stocks

PHIBRO ANIMAL HEALTH CORP

PAHCNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 6 good● 1 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$1.30B$1.02B$977.9M$942.3M$833.4M$800.4M
Operating income$110.5M$53.3M$71.8M$79.0M$74.9M$69.2M
Net income$48.3M$2.4M$32.6M$49.2M$54.4M$33.6M
Total assets$1.36B$982.2M$971.4M$931.7M$841.3M$784.1M
Total liabilities$1.08B$725.5M$688.9M$669.3M$602.8M$595.9M
Equity$285.7M$256.6M$282.5M$262.4M$238.5M$188.2M
EPS (diluted)$1.19$0.06$0.81$1.21$1.34$0.83
Shares out.40.7M40.5M40.5M40.5M40.5M40.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
8.5%
Net margin
3.7%
Return on equity
16.9%
Return on assets
3.5%
Return on capital (ROCE)
10.3%
Liabilities / assets
79.0%
Debt / equity
3.76×
Book value / share
$7.02
Revenue growth (YoY)
27.4%
Net income growth (YoY)
1897.7%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
3.97safe
Accruals / assets
−2.3%clean
Beneish M-Score
-2.34normal
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
88
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 1 warning● 6 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
1 acquisitions11 disposalsnet −5,278 shares · last 12
InsiderDateTypeSharesPrice
Bendheim JackOfficer — President and CEOMay 5, 2026Sell6,264$55.73
Bendheim JackOfficer — President and CEOApr 28, 2026Sell1,652$55.10
Bendheim JackOfficer — President and CEOApr 21, 2026Sell1,625$55.35
Bendheim JackOfficer — President and CEOApr 14, 2026Sell6,548$59.03
Bendheim JackOfficer — President and CEOMar 30, 2026Sell6,423$53.54
Bendheim JackOfficer — President and CEOMar 24, 2026Sell6,523$52.88
Bendheim JackOfficer — President and CEOMar 17, 2026Sell5,280$51.66
Bendheim JackOfficer — President and CEOMar 12, 2026Conversion100,000$0.00
Bendheim JackOfficer — President and CEOFeb 24, 2026Sell5,889$51.27
Bendheim JackOfficer — President and CEOFeb 19, 2026Sell7,040$50.26
Bendheim JackOfficer — President and CEOFeb 13, 2026Sell7,040$51.96
Bendheim JackOfficer — President and CEOFeb 10, 2026Sell50,994$51.76

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.2M2.0-3.0%
Apr 30, 20261.2M5.1-2.5%
Apr 15, 20261.2M4.4+6.7%
Mar 31, 20261.2M3.3-2.5%
Mar 13, 20261.2M4.7+10.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)